H.C. Wainwright Reiterates Neutral Rating, $2 PT on Akebia Therapeutics (AKBA)

Go back to H.C. Wainwright Reiterates Neutral Rating, $2 PT on Akebia Therapeutics (AKBA)
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 0.98 --0 (-0%)
Previous Close $0.98    52 Week High $13.20 
Open $0.98    52 Week Low $7.00 
Day High $0.98    P/E N/A 
Day Low $0.98    EPS $0.00 
Volume